Hall H Irene, Espinoza Lorena, Harris Shericka, Tang Tian, Mermin Jonathan
*Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA †ICF International, Atlanta, GA ‡National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta Georgia.
J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):e82-4. doi: 10.1097/QAI.0000000000000564.
Tipping point ratios <1 with fewer annual HIV infections than persons initiating HIV treatment indicate favorable epidemiologic situations to reduce HIV incidence. Using HIV surveillance data on persons newly diagnosed and virally suppressed in 2011 for 10 US jurisdictions, the tipping point ratio was 1.5 overall and ranged from 0.6 to 2.7. This indicates some jurisdictions have reached the point where the number of persons achieving viral suppression outpaces the number diagnosed with HIV. Expansion of treatment for all persons diagnosed with HIV as indicated in current treatment guidelines will benefit people living with HIV as well as prevention.
临界点比率小于1且年度新增艾滋病毒感染人数少于开始接受艾滋病毒治疗的人数,表明在降低艾滋病毒发病率方面存在有利的流行病学情况。利用美国10个司法管辖区2011年新诊断出并实现病毒抑制的人员的艾滋病毒监测数据,总体临界点比率为1.5,范围在0.6至2.7之间。这表明一些司法管辖区已达到实现病毒抑制的人数超过新诊断出艾滋病毒的人数的阶段。按照当前治疗指南的要求扩大对所有诊断出艾滋病毒的人员的治疗,将使艾滋病毒感染者受益,同时也有利于预防工作。